ICSI pregnancy outcomes following hysteroscopic placement of Essure devices for hydrosalpinx in laparoscopic contraindicated patients

Reproductive BioMedicine Online

Volumn 29, Issue 1, 2014, Pages 113-118

  Ozgur, Kemal ^a   Bulut, Hasan ^a   Berkkanoglu, Murat ^a   Coetzee, Kevin ^a,b   Kaya, Gamze ^a  

^a Antalya IVF   (Turkey)

^b Vitale   (Turkey)

Author keywords

Essure; hydrosalpinx; hysteroscopy; ICSI; laparoscopy; live birth

Indexed keywords

CETRORELIX; ESTRADIOL; ESTROFEM; GONADORELIN; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; PROGESTERONE; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; HUMAN; HYDROSALPINX; HYSTEROSCOPY; INTRACYTOPLASMIC SPERM INJECTION; LAPAROSCOPIC SURGERY; LAPAROSCOPY; LIVE BIRTH; MAJOR CLINICAL STUDY; PREGNANCY OUTCOME; PREGNANCY RATE; REPRODUCTION; TREATMENT CONTRAINDICATION; TUBAL OCCLUSION INSERT; UTERINE TUBE LIGATION; COMPARATIVE STUDY; COMPLICATION; DEVICES; FALLOPIAN TUBE DISEASES; INFERTILITY, FEMALE; PREGNANCY; PROCEDURES; RETROSPECTIVE STUDY; UTERINE TUBE STERILIZATION;

ADULT; FALLOPIAN TUBE DISEASES; FEMALE; HUMANS; HYSTEROSCOPY; INFERTILITY, FEMALE; LAPAROSCOPY; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; RETROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC; STERILIZATION, TUBAL;

EID: 84904044747     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2014.03.005     Document Type: Article

References (18)

1. M. Berkkanoglu, and K. Ozgur The optimum time interval of an ICSI/ET cycle with laparoscopic tubal occlusion for hydrosalpinges Fertil. Steril. 88 2007 S332
2. E. Camus, C. Poncelet, F. Goffinet, B. Wainer, F. Merlet, I. Nisand, and H.J. Phillipe Pregnancy rates after in-vitro fertilization in cases of tubal fertility with and without hydrosalpinx: a meta-analysis of published comparative studies Hum. Reprod. 14 1999 1243 1249
3. D.I. Galen, and N.M. Khan Use of Essure micro-insert for the treatment of hydrosalpinx prior to in vitro fertilization: a multicenter IDE/IRB off-label study Fertil. Steril. 94 2010 S55
4. M.B.E. Gerritse, S. Veersema, A. Timmermans, and H.A.M. Brölmann Incorrect position of Essure microinserts 3 monthsafter successful bilateral placement Fertil. Steril. 91 2009 e1 e5
5. J.A. Hitkari, S.S. Singh, H.M. Shapiro, and N. Leylan Essure treatment of hydrosalpinges Fertil. Steril. 88 2007 1663 1666
6. R. Hurskainen, S.-L. Hovi, M. Gissler, R. Grahn, K. Kukkonen-Harjula, M. Nord-Saari, and M. Makela Hysteroscopic tubal sterilization: a systematic review of the Essure system Fertil. Steril. 94 2010 16 19
7. N. Johnson, S. van Voorst, M.C. Sowter, A. Strandell, and B.W. Mol Surgical treatment for tubal disease in women due to undergo in vitro fertilization Cochrane Database Syst. Rev. 20 2010 CD002125
8. J.F. Kerin, and S. Cattanach Succesful pregnancy outcome with the use of in vitro ferilization after Essure hysteroscopic sterilization Fertil. Steril. 87 2007 1212 1214
9. V. Mijatovic, S. Veersema, M.H. Emanuel, R. Schats, and P.G.A. Hompes Essure hysteroscopic tubal occlusion device for the treatment of hydrosalpinx prior to in vitro fertilization-embryo transfer in patients with contraindication for laparoscopy Fertil. Steril. 93 2010 1338 1342
10. J.E. Nichols, and J.R. West Success of Essure© micro-inserts in the treatment of hydrosalpinx prior to in vitro fertilization (IVF)/frozen embryo transfer (FET) and pregnancy outcomes Fertil. Steril. 94 2010 S245
11. A. Rabanal, B. Prieto, R. Matorras, E. Urquijo, S. Diez, I. Brouard, and T. Martinez-Astorquiza Hysteroscopic treatment of hydrosalpinx prior to in vitro fertilization - embryo transfer (IVF-ET) Hum. Reprod. 25 2010 i64 i65
12. J. Rios Castillo, E. Velasco Sanchez, B. Povedano Canizares, M. de Andres Cara, J. Lorent Gonzalez, and J.E. Arjona Berral Longterm efficacy of female sterilization with Essure device Hum. Reprod. 26 2011 i247
13. V. Shah, N. Panay, R. Williamson, and A. Hemingway Hysterosalpingogram: an essential examination following Essure hysteroscopic sterilisation Br. J. Radiol. 84 2011 805 812
14. A. Strandell, and A. Lindhard Why does hydrosalpinx reduce fertility? Hum. Reprod. 17 2002 1141 1145
15. A. Strandell, A. Lindhard, U. Waldenstrom, J. Thorburn, P.O. Janson, and L. Hamberger Hydrosalpinx and IVF outcome: a prospective, randomized multicentre trial in Scandinavia on salpingectomy prior to IVF Hum. Reprod. 14 1999 2762 2769
16. A. Strandell, A. Lindhard, U. Waldenstrom, and J. Thornburn Hydrosalpinx and IVF outcome: cumulative results after salpingectomy in a randomized controlled trial Hum. Reprod. 16 2001 2403 2410
17. A. Ubeda, R. Labastida, and S. Dexeus Essure®: a new device for hysteroscopic tubal sterilization in an outpatient setting Fertil. Steril. 82 2004 196 199
18. E. Velasco Sanchez, J. Rios Castillo, J.E. Arjona Berral, B. Povedano Canizares, J. Lorent Gonzalez, and M. de Andres Cara Pregnancy outcomes and perinatal results of unintended pregnancies following EssureR sterilization: descriptive study of 10 cases Hum. Reprod. 26 2011 i247